CareDx (CDNA) & Digiliti Money Group (DGLT) Head to Head Review
CareDx (NASDAQ: CDNA) and Digiliti Money Group (OTCMKTS:DGLT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership.
Volatility & Risk
CareDx has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Digiliti Money Group has a beta of -0.66, indicating that its share price is 166% less volatile than the S&P 500.
This is a summary of recent recommendations and price targets for CareDx and Digiliti Money Group, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Digiliti Money Group||0||0||1||0||3.00|
CareDx presently has a consensus target price of $8.88, suggesting a potential upside of 29.18%. Digiliti Money Group has a consensus target price of $6.00, suggesting a potential upside of 4,185.71%. Given Digiliti Money Group’s higher possible upside, analysts clearly believe Digiliti Money Group is more favorable than CareDx.
Insider & Institutional Ownership
23.2% of CareDx shares are held by institutional investors. Comparatively, 11.3% of Digiliti Money Group shares are held by institutional investors. 5.4% of CareDx shares are held by insiders. Comparatively, 50.9% of Digiliti Money Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares CareDx and Digiliti Money Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Digiliti Money Group||-147.73%||N/A||-199.21%|
Valuation & Earnings
This table compares CareDx and Digiliti Money Group’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|CareDx||$40.63 million||4.83||-$39.46 million||($1.81)||-3.80|
|Digiliti Money Group||$7.97 million||0.17||-$15.16 million||N/A||N/A|
Digiliti Money Group has lower revenue, but higher earnings than CareDx.
CareDx beats Digiliti Money Group on 7 of the 11 factors compared between the two stocks.
CareDx Company Profile
CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company’s commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.
Digiliti Money Group Company Profile
Digiliti Money Group, Inc., formerly Digiliti Money, Inc., is a technology solutions and services provider to the financial services industry. The Company’s solutions and services enable its clients, such as banks, credit unions and alternative financial services providers (AFS) to offer their customers remote deposit capture (RDC) and prepaid mobile money technologies and related services. It offers RDC products for businesses and consumers; mobile money management products for consumers, and training and support services for its financial services industry customers. The RDC products are offered to banks and credit unions in the United States, Canada and Latin America. Its mobile money management products are offered to traditional financial institutions (FIs), as well as AFS in the United States, Canada and Latin America. These FIs and AFS providers include banks, credit unions, prepaid card issuers, check cashers and payday lenders.
Receive News & Ratings for CareDx Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx Inc. and related companies with MarketBeat.com's FREE daily email newsletter.